In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
about
Mouse models of Down syndrome as a tool to unravel the causes of mental disabilitiesThe contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models.Expression profile analysis of hippocampal CA1 pyramidal neurons in aged Ts65Dn mice, a model of Down syndrome (DS) and Alzheimer's disease (AD).Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.Neuroinflammatory Cytokines-The Common Thread in Alzheimer's PathogenesisWorking memory in the aged Ts65Dn mouse, a model for Down syndromeMolecular and cellular alterations in Down syndrome: toward the identification of targets for therapeuticsMaternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging studyPartial BACE1 reduction in a Down syndrome mouse model blocks Alzheimer-related endosomal anomalies and cholinergic neurodegeneration: role of APP-CTF.Systemic pathology in aged mouse models of Down's syndrome and Alzheimer's disease.Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome.Nerve growth factor metabolic dysfunction in Down's syndrome brains.Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update.Intellectual disability is a risk factor for delayed emergence from total intravenous anaesthesia.Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.Basal forebrain involvement in low-functioning autistic children: a voxel-based morphometry study.Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging
P2860
Q26863005-0B2D320F-2B37-4997-87F9-1F9245C76D18Q33823446-35DF0CDA-9C71-4247-AEC8-DBBD827A000CQ34979826-E940065F-D2F9-4AF8-8978-79BCA74952D6Q35551607-D9328F22-D718-44AB-905D-AE9254A35547Q35815212-093734E4-FD64-4CF2-AD09-3C4568A3218EQ36004329-AA4DE207-D876-4EAD-9324-4EB4731F800BQ36111546-6F1745AC-82D6-4686-9237-A38A12BA9F9EQ36522425-66FB6660-A8EF-4316-AE50-D03588C1593AQ36563018-87FF07EA-7700-4205-BBCD-AACEF40F16A7Q36638747-695D9769-E26E-42BD-B95A-E422F58A7FE6Q37137397-4331E07C-7832-4F0F-B415-8C732BA7DD96Q37279515-74584300-D303-4D8A-B2B6-3E46D07BFD95Q37590669-8C82E0EE-2986-43E5-8213-83F421E77C83Q37647989-6A9F91BE-417F-43BB-AC97-54BB512C70FFQ37998086-208CF653-5C4E-41CE-B53A-AB5D31B31F80Q47203258-81D0B56D-A805-456B-8DB7-C2FDD500EDC1Q47289623-8538242A-2ABA-4233-8227-A3F077BFE978Q49132711-C1E4FB83-A572-4857-A665-206657D86576Q49497621-DA39E56D-2B47-4B0E-A6AF-99AD200A6B1AQ58761442-7606BECF-544D-45D7-AFD0-BA96AC5123A6
P2860
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@en
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@nl
type
label
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@en
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@nl
prefLabel
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@en
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
@nl
P2093
P2860
P1476
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
@en
P2093
Anne M Cataldo
Babak Ardekani
Corrinne Peterhoff
Craig A Branch
David N Guilfoyle
Dunsheng Yang
Ralph A Nixon
Victor V Dyakin
Yuanxin Chen
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2007.11.026
P577
2008-01-03T00:00:00Z